Scinai Immunotherapeutics Share Are Trading Higher After the Company Announced Today the Establishment of a U.S.-based Subsidiary for Its Contract Development and Manufacturing Services.

Benzinga12/16 22:26

Scinai Immunotherapeutics Announces The Establishment Of A U.S.-Based Subsidiary For Its Contract Development And Manufacturing Services

Benzinga12/16 22:26

Press Release: Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board

Dow Jones12/05 21:25

Scinai Immunotherapeutics' (NASDAQ:SCNI) Earnings Might Be Weaker Than You Think

Simply Wall St11/29 19:21

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga11/23 05:06

Scinai Immunotherapeutics 3Q Rev $168,000 >SCNI

Dow Jones11/22 20:15